- Home
- VEEA vs CRVO Comparison
VEEA vs CRVO Comparison
Compare VEEA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEA
- CRVO
- Stock Information
- Founded
- VEEA 2014
- CRVO 2001
- Country
- VEEA United States
- CRVO United States
- Employees
- VEEA N/A
- CRVO N/A
- Industry
- VEEA
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- VEEA
- CRVO Health Care
- Exchange
- VEEA NYSE
- CRVO Nasdaq
- Market Cap
- VEEA 112.2M
- CRVO 95.4M
- IPO Year
- VEEA N/A
- CRVO N/A
- Fundamental
- Price
- VEEA $1.56
- CRVO $9.48
- Analyst Decision
- VEEA
- CRVO Strong Buy
- Analyst Count
- VEEA 0
- CRVO 8
- Target Price
- VEEA N/A
- CRVO $25.43
- AVG Volume (30 Days)
- VEEA 22.6K
- CRVO 13.7M
- Earning Date
- VEEA 05-23-2025
- CRVO 03-17-2025
- Dividend Yield
- VEEA N/A
- CRVO N/A
- EPS Growth
- VEEA N/A
- CRVO N/A
- EPS
- VEEA N/A
- CRVO N/A
- Revenue
- VEEA $140,035.00
- CRVO $9,737,974.00
- Revenue This Year
- VEEA N/A
- CRVO N/A
- Revenue Next Year
- VEEA N/A
- CRVO N/A
- P/E Ratio
- VEEA N/A
- CRVO N/A
- Revenue Growth
- VEEA N/A
- CRVO 36.29
- 52 Week Low
- VEEA $1.33
- CRVO $1.80
- 52 Week High
- VEEA $18.56
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- VEEA N/A
- CRVO 61.07
- Support Level
- VEEA N/A
- CRVO $7.13
- Resistance Level
- VEEA N/A
- CRVO $10.72
- Average True Range (ATR)
- VEEA 0.00
- CRVO 2.50
- MACD
- VEEA 0.00
- CRVO 0.07
- Stochastic Oscillator
- VEEA 0.00
- CRVO 50.33
About VEEA VEEA INC
Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.